Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 51

1.

Disruption of APOL1-miR193a Axis Induces Disorganization of Podocyte Actin Cytoskeleton.

Kumar V, Paliwal N, Ayasolla K, Vashistha H, Jha A, Chandel N, Chowdhary S, Saleem MA, Malhotra A, Chander PN, Skorecki K, Singhal PC.

Sci Rep. 2019 Mar 5;9(1):3582. doi: 10.1038/s41598-019-39376-y.

2.

Role of Apolipoprotein L1 in Human Parietal Epithelial Cell Transition.

Kumar V, Vashistha H, Lan X, Chandel N, Ayasolla K, Shoshtari SSM, Aslam R, Paliwal N, Abbruscato F, Mikulak J, Popik W, Atta MG, Chander PN, Malhotra A, Meyer-Schwesinger C, Skorecki K, Singhal PC.

Am J Pathol. 2018 Nov;188(11):2508-2528. doi: 10.1016/j.ajpath.2018.07.025. Epub 2018 Sep 8.

PMID:
30201495
3.

Thrombotic microangiopathy associated with synthetic cannabinoid receptor agonists.

Karass M, Chugh S, Andries G, Mamorska-Dyga A, Nelson JC, Chander PN.

Stem Cell Investig. 2017 May 26;4:43. doi: 10.21037/sci.2017.05.05. eCollection 2017.

4.

Autoimmune sclerosing cholangitis: An atypical association with kawasaki disease.

Rosencrantz RA, Huang T, Sonke PY, Tewari D, Chander PN.

Hepatology. 2016 Dec;64(6):2253-2256. doi: 10.1002/hep.28694. Epub 2016 Jul 29. No abstract available.

PMID:
27333792
5.

HIV Promotes NLRP3 Inflammasome Complex Activation in Murine HIV-Associated Nephropathy.

Haque S, Lan X, Wen H, Lederman R, Chawla A, Attia M, Bongu RP, Husain M, Mikulak J, Saleem MA, Popik W, Malhotra A, Chander PN, Singhal PC.

Am J Pathol. 2016 Feb;186(2):347-58. doi: 10.1016/j.ajpath.2015.10.002. Epub 2015 Dec 10.

6.

Epigenetic Modulation of Human Podocyte Vitamin D Receptor in HIV Milieu.

Chandel N, Ayasolla KS, Lan X, Sultana-Syed M, Chawla A, Lederman R, Vethantham V, Saleem MA, Chander PN, Malhotra A, Singhal PC.

J Mol Biol. 2015 Oct 9;427(20):3201-3215. doi: 10.1016/j.jmb.2015.07.011. Epub 2015 Jul 22.

7.

Apolipoprotein L1 (APOL1) Variants (Vs) a possible link between Heroin-associated Nephropathy (HAN) and HIV-associated Nephropathy (HIVAN).

Lan X, Rao TK, Chander PN, Skorecki K, Singhal PC.

Front Microbiol. 2015 Jun 9;6:571. doi: 10.3389/fmicb.2015.00571. eCollection 2015. Review.

8.

AT1R blockade in adverse milieus: role of SMRT and corepressor complexes.

Singh T, Ayasolla K, Rai P, Chandel N, Haque S, Lederman R, Husain M, Vethantham V, Chawla A, Vashistha H, Saleem MA, Ding G, Chander PN, Malhotra A, Meggs LG, Singhal PC.

Am J Physiol Renal Physiol. 2015 Aug 1;309(3):F189-203. doi: 10.1152/ajprenal.00476.2014. Epub 2015 Jun 17.

9.

Curtailing endothelial TGF-β signaling is sufficient to reduce endothelial-mesenchymal transition and fibrosis in CKD.

Xavier S, Vasko R, Matsumoto K, Zullo JA, Chen R, Maizel J, Chander PN, Goligorsky MS.

J Am Soc Nephrol. 2015 Apr;26(4):817-29. doi: 10.1681/ASN.2013101137. Epub 2014 Dec 22.

10.

Azilsartan is associated with increased circulating angiotensin-(1-7) levels and reduced renovascular 20-HETE levels.

Carroll MA, Kang Y, Chander PN, Stier CT Jr.

Am J Hypertens. 2015 May;28(5):664-71. doi: 10.1093/ajh/hpu201. Epub 2014 Nov 10.

PMID:
25384409
11.

Pharmacological manipulation of arachidonic acid-epoxygenase results in divergent effects on renal damage.

Li J, Stier CT, Chander PN, Manthati VL, Falck JR, Carroll MA.

Front Pharmacol. 2014 Aug 15;5:187. doi: 10.3389/fphar.2014.00187. eCollection 2014.

12.

Modulation of renin angiotensin system predominantly alters sclerotic phenotype of glomeruli in HIVAN.

Plagov A, Lan X, Rai P, Kumar D, Lederman R, Rehman S, Malhotra A, Ding G, Chander PN, Singhal PC.

Histol Histopathol. 2014 Dec;29(12):1575-81. doi: 10.14670/HH-29.1575. Epub 2014 Jun 3.

13.

mTOR plays a critical role in p53-induced oxidative kidney cell injury in HIVAN.

Rai P, Plagov A, Lan X, Chandel N, Singh T, Lederman R, Ayasolla KR, Mathieson PW, Saleem MA, Husain M, Malhotra A, Chander PN, Singhal PC.

Am J Physiol Renal Physiol. 2013 Aug 1;305(3):F343-54. doi: 10.1152/ajprenal.00135.2013. Epub 2013 May 15.

14.

Collapsing glomerulopathy in 19 patients with systemic lupus erythematosus or lupus-like disease.

Salvatore SP, Barisoni LM, Herzenberg AM, Chander PN, Nickeleit V, Seshan SV.

Clin J Am Soc Nephrol. 2012 Jun;7(6):914-25. doi: 10.2215/CJN.11751111. Epub 2012 Mar 29.

15.

HIV-associated nephropathy: role of AT2R.

Salhan D, Sagar A, Kumar D, Rattanavich R, Rai P, Maheshwari S, Adabala M, Husain M, Ding G, Malhotra A, Chander PN, Singhal PC.

Cell Signal. 2012 Mar;24(3):734-41. doi: 10.1016/j.cellsig.2011.11.007. Epub 2011 Nov 13.

16.

Adverse host factors exacerbate occult HIV-associated nephropathy.

Kumar D, Salhan D, Magoon S, Torri DD, Sayeneni S, Sagar A, Bandhlish A, Malhotra A, Chander PN, Singhal PC.

Am J Pathol. 2011 Oct;179(4):1681-92. doi: 10.1016/j.ajpath.2011.06.013. Epub 2011 Aug 24.

17.

Diffuse infiltrative lymphocytosis syndrome presenting as reversible acute kidney injury associated with Gram-negative bacterial infection in patients with newly diagnosed HIV infection.

Yoo J, Baumstein D, Kuppachi S, Singh A, Chander PN.

Am J Kidney Dis. 2011 May;57(5):752-5. doi: 10.1053/j.ajkd.2010.12.010. Epub 2011 Feb 4.

PMID:
21295898
18.

HIV-associated nephropathy: role of mammalian target of rapamycin pathway.

Kumar D, Konkimalla S, Yadav A, Sataranatarajan K, Kasinath BS, Chander PN, Singhal PC.

Am J Pathol. 2010 Aug;177(2):813-21. doi: 10.2353/ajpath.2010.100131. Epub 2010 Jun 25.

19.

HIVAN phenotype: consequence of epithelial mesenchymal transdifferentiation.

Yadav A, Vallabu S, Kumar D, Ding G, Charney DN, Chander PN, Singhal PC.

Am J Physiol Renal Physiol. 2010 Mar;298(3):F734-44. doi: 10.1152/ajprenal.00415.2009. Epub 2009 Dec 16.

20.

Human immunodeficiency virus downregulates podocyte apoE expression.

Arora S, Husain M, Kumar D, Patni H, Pathak S, Mehrotra D, Reddy VK, Reddy LR, Salhan D, Yadav A, Mathieson PW, Saleem MA, Chander PN, Singhal PC.

Am J Physiol Renal Physiol. 2009 Sep;297(3):F653-61. doi: 10.1152/ajprenal.90668.2008. Epub 2009 Jun 24.

21.

Adoptive transfer of syngeneic bone marrow-derived cells in mice with obesity-induced diabetes: selenoorganic antioxidant ebselen restores stem cell competence.

Chen J, Li H, Addabbo F, Zhang F, Pelger E, Patschan D, Park HC, Kuo MC, Ni J, Gobe G, Chander PN, Nasjletti A, Goligorsky MS.

Am J Pathol. 2009 Feb;174(2):701-11. doi: 10.2353/ajpath.2009.080606. Epub 2009 Jan 15.

22.

Urinary proteomic analysis of chronic allograft nephropathy.

O'Riordan E, Orlova TN, Mendelev N, Patschan D, Kemp R, Chander PN, Hu R, Hao G, Gross SS, Iozzo RV, Delaney V, Goligorsky MS.

Proteomics Clin Appl. 2008 Jul;2(7-8):1025-35. doi: 10.1002/prca.200780137.

23.

Soluble epoxide hydrolase inhibitor, AUDA, prevents early salt-sensitive hypertension.

Li J, Carroll MA, Chander PN, Falck JR, Sangras B, Stier CT.

Front Biosci. 2008 May 1;13:3480-7.

PMID:
18508449
24.

Aldosterone, but not angiotensin II, increases profibrotic factors in kidney of adrenalectomized stroke-prone spontaneously hypertensive rats.

Chun TY, Chander PN, Kim JW, Pratt JH, Stier CT Jr.

Am J Physiol Endocrinol Metab. 2008 Aug;295(2):E305-12. doi: 10.1152/ajpendo.00512.2007. Epub 2008 May 20.

25.

Aldosterone induces mesangial cell apoptosis both in vivo and in vitro.

Mathew JT, Patni H, Chaudhary AN, Liang W, Gupta A, Chander PN, Ding G, Singhal PC.

Am J Physiol Renal Physiol. 2008 Jul;295(1):F73-81. doi: 10.1152/ajprenal.00435.2007. Epub 2008 May 7.

26.

Dysregulation of mitochondrial biogenesis in vascular endothelial and smooth muscle cells of aged rats.

Ungvari Z, Labinskyy N, Gupte S, Chander PN, Edwards JG, Csiszar A.

Am J Physiol Heart Circ Physiol. 2008 May;294(5):H2121-8. doi: 10.1152/ajpheart.00012.2008. Epub 2008 Mar 7.

27.

Aldosterone promotes proximal tubular cell apoptosis: role of oxidative stress.

Patni H, Mathew JT, Luan L, Franki N, Chander PN, Singhal PC.

Am J Physiol Renal Physiol. 2007 Oct;293(4):F1065-71. Epub 2007 Aug 1.

28.

Characterization of urinary peptide biomarkers of acute rejection in renal allografts.

O'Riordan E, Orlova TN, Podust VN, Chander PN, Yanagi S, Nakazato M, Hu R, Butt K, Delaney V, Goligorsky MS.

Am J Transplant. 2007 Apr;7(4):930-40. Epub 2007 Feb 28.

29.

Normal distribution and medullary-to-cortical shift of Nestin-expressing cells in acute renal ischemia.

Patschan D, Michurina T, Shi HK, Dolff S, Brodsky SV, Vasilieva T, Cohen-Gould L, Winaver J, Chander PN, Enikolopov G, Goligorsky MS.

Kidney Int. 2007 Apr;71(8):744-54. Epub 2007 Feb 7.

30.

Idiopathic nodular glomerulosclerosis in a non-diabetic hypertensive smoker--case report and review of literature.

Kuppachi S, Idris N, Chander PN, Yoo J.

Nephrol Dial Transplant. 2006 Dec;21(12):3571-5. Epub 2006 Sep 5. Review. No abstract available.

PMID:
16954177
31.

Heme oxygenase-2 deficiency contributes to diabetes-mediated increase in superoxide anion and renal dysfunction.

Goodman AI, Chander PN, Rezzani R, Schwartzman ML, Regan RF, Rodella L, Turkseven S, Lianos EA, Dennery PA, Abraham NG.

J Am Soc Nephrol. 2006 Apr;17(4):1073-81. Epub 2006 Mar 8.

32.

Effect of aldosterone and MR blockade on the brain and the kidney.

Stier CT Jr, Rocha R, Chander PN.

Heart Fail Rev. 2005 Jan;10(1):53-62. Review.

PMID:
15947892
33.

Male gender and not the severity of hypertension is associated with end-organ damage in aged stroke-prone spontaneously hypertensive rats.

Masineni SN, Chander PN, Singh GD, Powers CA, Stier CT Jr.

Am J Hypertens. 2005 Jun;18(6):878-84.

PMID:
15925751
34.

Endothelial dysfunction as a modifier of angiogenic response in Zucker diabetic fat rat: amelioration with Ebselen.

Gealekman O, Brodsky SV, Zhang F, Chander PN, Friedli C, Nasjletti A, Goligorsky MS.

Kidney Int. 2004 Dec;66(6):2337-47.

35.

Nephropathy in Zucker diabetic fat rat is associated with oxidative and nitrosative stress: prevention by chronic therapy with a peroxynitrite scavenger ebselen.

Chander PN, Gealekman O, Brodsky SV, Elitok S, Tojo A, Crabtree M, Gross SS, Goligorsky MS.

J Am Soc Nephrol. 2004 Sep;15(9):2391-403.

36.

Sodium transport antagonism reduces thrombotic microangiopathy in stroke-prone spontaneously hypertensive rats.

Sepehrdad R, Chander PN, Singh G, Stier CT Jr.

Am J Physiol Renal Physiol. 2004 Jun;286(6):F1185-92. Epub 2004 Feb 24.

37.

Aldosterone plays a pivotal role in the pathogenesis of thrombotic microangiopathy in SHRSP.

Chander PN, Rocha R, Ranaudo J, Singh G, Zuckerman A, Stier CT Jr.

J Am Soc Nephrol. 2003 Aug;14(8):1990-7.

38.

CD137 costimulatory T cell receptor engagement reverses acute disease in lupus-prone NZB x NZW F1 mice.

Foell J, Strahotin S, O'Neil SP, McCausland MM, Suwyn C, Haber M, Chander PN, Bapat AS, Yan XJ, Chiorazzi N, Hoffmann MK, Mittler RS.

J Clin Invest. 2003 May;111(10):1505-18.

39.

Estrogen promotes microvascular pathology in female stroke-prone spontaneously hypertensive rats.

Stier CT Jr, Chander PN, Rosenfeld L, Powers CA.

Am J Physiol Endocrinol Metab. 2003 Jul;285(1):E232-9. Epub 2003 Apr 1.

40.

Amiloride reduces stroke and renalinjury in stroke-prone hypertensive rats.

Sepehrdad R, Chander PN, Oruene A, Rosenfeld L, Levine S, Stier CT Jr.

Am J Hypertens. 2003 Apr;16(4):312-8.

PMID:
12670749
41.

Aldosterone as a mediator in cardiovascular injury.

Stier CT Jr, Chander PN, Rocha R.

Cardiol Rev. 2002 Mar-Apr;10(2):97-107. Review.

PMID:
11895576
42.

Inhibition of NOS enhances pulmonary vascular changes in stroke-prone spontaneously hypertensive rats.

Mathew R, Fan NY, Yuan N, Chander PN, Gewitz MH, Stier CT Jr.

Am J Physiol Lung Cell Mol Physiol. 2000 Jan;278(1):L81-9.

43.

Role of aldosterone in renal vascular injury in stroke-prone hypertensive rats.

Rocha R, Chander PN, Zuckerman A, Stier CT Jr.

Hypertension. 1999 Jan;33(1 Pt 2):232-7.

PMID:
9931110
44.

Mineralocorticoid blockade reduces vascular injury in stroke-prone hypertensive rats.

Rocha R, Chander PN, Khanna K, Zuckerman A, Stier CT Jr.

Hypertension. 1998 Jan;31(1 Pt 2):451-8.

PMID:
9453344
45.

Regional renal nitric oxide release in stroke-prone spontaneously hypertensive rats.

Zuckerman A, Chander PN, Zeballos GA, Stier CT Jr.

Hypertension. 1997 Dec;30(6):1479-86.

PMID:
9403570
46.

Beneficial action of beraprost sodium, a prostacyclin analog, in stroke-prone rats.

Stier CT Jr, Chander PN, Belmonte A, Inamdar RS, Mistry M.

J Cardiovasc Pharmacol. 1997 Sep;30(3):285-93.

PMID:
9300310
47.

Stroke prevention by losartan in stroke-prone spontaneously hypertensive rats.

Stier CT Jr, Adler LA, Levine S, Chander PN.

J Hypertens Suppl. 1993 Apr;11(3):S37-42.

PMID:
8315518
48.

The antiproteinuric action of enalapril in stroke-prone spontaneously hypertensive rats is unrelated to alterations in urinary prostaglandins.

Stier CT Jr, Mahboubi K, DiPippo VA, Levine S, Chander PN.

J Pharmacol Exp Ther. 1992 Mar;260(3):1410-5.

PMID:
1545401
49.

The lipoxygenase inhibitor phenidone protects against proteinuria and stroke in stroke-prone spontaneously hypertensive rats.

Munsiff AV, Chander PN, Levine S, Stier CT Jr.

Am J Hypertens. 1992 Feb;5(2):56-63.

PMID:
1550666
50.

Arachidonic acid metabolism in a cell suspension isolated from rabbit renal outer medulla.

Ferreri NR, Schwartzman M, Ibraham NG, Chander PN, McGiff JC.

J Pharmacol Exp Ther. 1984 Nov;231(2):441-8.

PMID:
6436472

Supplemental Content

Loading ...
Support Center